Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average rating of “Moderate Buy” from ...